PPARD and metabolic syndrome: The results of this study indicated that PPARD rs2016520 and rs2267668 polymorphisms are not associated with any of the metabolic-related diseases including obesity, dyslipidemia, hyperhomocysteinemia, hyperuricemia, hypertension, T2DM and CAD.